Lv42
548 积分 2022-01-28 加入
Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia
21天前
已完结
Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study
21天前
已完结
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
22天前
已完结
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
22天前
已完结
Familial hypercholesterolaemia: summary of NICE guidance
22天前
已关闭
Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review
22天前
已完结
Familial hypercholesterolaemia: summary of NICE guidance
23天前
已关闭
[Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)]
28天前
已完结
皖公网安备34019202002308
